Florence K. Keane

2.0k total citations · 1 hit paper
58 papers, 1.3k citations indexed

About

Florence K. Keane is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Florence K. Keane has authored 58 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 13 papers in Surgery. Recurrent topics in Florence K. Keane's work include Lung Cancer Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (9 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Florence K. Keane is often cited by papers focused on Lung Cancer Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (9 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Florence K. Keane collaborates with scholars based in United States, Germany and Canada. Florence K. Keane's co-authors include Anna F. Farago, Ravi A. Chandra, Charles R. Thomas, Francine E.M. Voncken, Clemens Grassberger, Moses Q. Wilks, Susannah G. Ellsworth, Jay S. Loeffler, Theodore S. Hong and Andrew X. Zhu and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Florence K. Keane

54 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contemporary radiotherapy: present and future

2021 228 citations Ravi A. Chandra, Florence K. Keane et al. The Lancet profile →

Peers

Countries citing papers authored by Florence K. Keane

Since Specialization

Citations

This map shows the geographic impact of Florence K. Keane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence K. Keane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence K. Keane more than expected).

Fields of papers citing papers by Florence K. Keane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence K. Keane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence K. Keane. The network helps show where Florence K. Keane may publish in the future.

Co-authorship network of co-authors of Florence K. Keane

This figure shows the co-authorship network connecting the top 25 collaborators of Florence K. Keane. A scholar is included among the top collaborators of Florence K. Keane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence K. Keane. Florence K. Keane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	QOL-28. The experience of patients with lung cancer with brain metastases: neurocognitive deficits and patient-reported functional difficulties and mood 2025 ·Neuro-Oncology ·M. Boulanger, Stephen Lo, Daniel Chiu, Kelcie Willis, Deborah Forst, Nancy Wang, Florence K. Keane, Joseph A. Greer, Jennifer S. Temel, Laura A. Petrillo	0
2	Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kinase Inhibitors 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Florence K. Keane, Beow Y. Yeap, Melin J. Khandekar, W. Marston Linehan, Ibiayi Dagogo‐Jack, Lecia V. Sequist, Zofia Piotrowska, Henning Willers	0
3	Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study 2023 ·JTO Clinical and Research Reports ·(unknown), Alice Tzeng, (unknown), (unknown), Kelly Fitzgerald, Jaclyn LoPiccolo, (unknown), Daniel E. Soto, Julia Rotow, Lisa Singer, Henning Willers, David Kozono, Pasi A. Jänne, Raymond H. Mak, Zofia Piotrowska, Florence K. Keane, Benjamin H. Kann	6
4	Effect of Contralateral Esophagus Sparing in Hypofractionated Radiotherapy for Ultra-Central NSCLC 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Lingling Zhu, Melin J. Khandekar, Ji‐Hoon Choi, (unknown), Henning Willers, Florence K. Keane	1
5	Diagnosis and Treatment of Lung Cancer in the Setting of Interstitial Lung Disease 2022 ·Radiologic Clinics of North America ·(unknown), Mark C. Murphy, Sydney B. Montesi, Lida P. Hariri, Robert W. Hallowell, Florence K. Keane, (unknown), Meghan J. Mooradian, Florian J. Fintelmann	9
6	A Systematic Comparison of Dose Distributions Delivered in 125I Plaque Brachytherapy and Proton Radiation Therapy for Ocular Melanoma 2022 ·International Journal of Radiation OncologyBiologyPhysics ·Alexei Trofimov, Mary E. Aronow, Evangelos S. Gragoudas, Florence K. Keane, Ivana K. Kim, Helen A. Shih, Mandar S. Bhagwat	6
7	Contemporary radiotherapy: present and future breakdown → 2021 ·The Lancet ·Ravi A. Chandra, Florence K. Keane, Francine E.M. Voncken, Charles R. Thomas	228
8	Automated clinical target volume delineation using deep 3D neural networks in radiation therapy of Non-small Cell Lung Cancer 2021 ·Physics and Imaging in Radiation Oncology ·Yunhe Xie, (unknown), Yi Wang, Melin J. Khandekar, Henning Willers, Florence K. Keane, Thomas Bortfeld	8
9	Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy 2021 ·Radiotherapy and Oncology ·(unknown), Vivek Naranbhai, Kerri St. Denis, Evan C. Lam, (unknown), Florence K. Keane, Melin J. Khandekar, Alejandro B. Balazs, John Iafrate, Justin F. Gainor, Henning Willers	9
10	Neoadjuvant versus Postoperative Chemoradiotherapy is Associated with Improved Survival for Patients with Resectable Gastric and Gastroesophageal Cancer 2021 ·Annals of Surgical Oncology ·Daniel W. Kim, Grace Lee, Theodore S. Hong, Guichao Li, Nora Horick, Eric Roeland, Florence K. Keane, Christine E. Eyler, Lorraine C. Drapek, David P. Ryan, Jill N. Allen, David L. Berger, Aparna R. Parikh, John T. Mullen, (unknown), Jeffrey W. Clark, Jennifer Y. Wo	5
11	Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game? 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Daniel T. Chang, Erqi L. Pollom, Florence K. Keane, Jennifer Y. Wo	6
12	Low Rates of Chest Wall Toxicity When Individualizing the Planning Target Volume Margin in Patients With Early Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy 2020 ·Practical Radiation Oncology ·Florence K. Keane, (unknown), (unknown), Brittany G. Durgin, Melin J. Khandekar, Henning Willers	3
13	Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer 2019 ·Radiotherapy and Oncology ·Nikhil Sebastian, Trudy C. Wu, (unknown), Henning Willers, Suzanne M. Kelly, Hima Bindu Musunuru, Xiaokui Mo, Yubo Tan, Jose G. Bazan, Karl Haglund, Meng Xu‐Welliver, (unknown), Andrew Ju, Florence K. Keane, Terence M. Williams	2
14	Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes 2019 ·Annals of Surgical Oncology ·Jon M. Harrison, Jennifer Y. Wo, Cristina R. Ferrone, Nora Horick, Florence K. Keane, Motaz Qadan, Keith D. Lillemoe, Theodore S. Hong, Jeffrey W. Clark, Lawrence S. Blaszkowsky, Jill N. Allen, Carlos Fernández‐del Castillo	24
15	Differential inflammatory response dynamics in normal lung following stereotactic body radiation therapy with protons versus photons 2019 ·Radiotherapy and Oncology ·Yanjing Li, Michael Dykstra, Till D. Best, J. Pursley, (unknown), Florence K. Keane, Melin J. Khandekar, G Sharp, Harald Paganetti, Henning Willers, Florian J. Fintelmann, Clemens Grassberger	16
16	Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy 2018 ·Seminars in Radiation Oncology ·Florence K. Keane, Theodore S. Hong, Andrew X. Zhu	10
17	Liver-Directed Radiotherapy for Hepatocellular Carcinoma 2016 ·Liver Cancer ·Florence K. Keane, Jennifer Y. Wo, Andrew X. Zhu, Theodore S. Hong	25
18	Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial 2015 ·Practical Radiation Oncology ·Joshua R. Niska, Florence K. Keane, John A. Wolfgang, Peter F. Hahn, Jennifer Y. Wo, Andrew X. Zhu, Theodore S. Hong	9
19	A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis 2011 ·The Lancet Oncology ·Trupti Paranjape, Helen Heneghan, Robert Lindner, Florence K. Keane, Aaron E. Hoffman, Antoinette Hollestelle, (unknown), (unknown), (unknown), Sunitha Nallur, John W.M. Martens, Maartje J. Hooning, Michael J. Kerin, Daniel Zelterman, Yongxue Zhu, David Tuck, Lyndsay N. Harris, Nicola Miller, Frank J. Slack, Joanne B. Weidhaas	101
20	The KRAS-Variant Genetic Test As a Marker of Increased Risk of Ovarian Cancer. 2010 ·PubMed Central ·Florence K. Keane, Elena Ratner	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact